| 000 | 01633 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511210256.0 | ||
| 264 | 0 | _c19910403 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0732-8141 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTerao, S | |
| 245 | 0 | 0 |
_aSynthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS). _h[electronic resource] |
| 260 |
_bAdvances in prostaglandin, thromboxane, and leukotriene research _c1991 |
||
| 300 |
_a173-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xbiosynthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xchemical synthesis |
| 650 | 0 | 4 |
_aBenzoquinones _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFree Radicals |
| 650 | 0 | 4 |
_aGlomerulonephritis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukotriene B4 _xbiosynthesis |
| 650 | 0 | 4 | _aLipoxygenase Inhibitors |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aOxygen _xmetabolism |
| 650 | 0 | 4 |
_aPuromycin Aminonucleoside _xtoxicity |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aThromboxane B2 _xbiosynthesis |
| 650 | 0 | 4 |
_aThromboxane-A Synthase _xantagonists & inhibitors |
| 700 | 1 | _aOhkawa, S | |
| 700 | 1 | _aTerashita, Z | |
| 700 | 1 | _aShibouta, Y | |
| 700 | 1 | _aNishikawa, K | |
| 773 | 0 |
_tAdvances in prostaglandin, thromboxane, and leukotriene research _gvol. 21A _gp. 173-6 |
|
| 999 |
_c1853965 _d1853965 |
||